BARRIER THERAPEUTICS INC 4
4 · BARRIER THERAPEUTICS INC · Filed Aug 6, 2008
Insider Transaction Report
Form 4
BRISTOW ALBERT
General Counsel and Secretary
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2008-08-06−32,000→ 0 totalExercise: $1.50Exp: 2013-10-21→ Common Stock (32,000 underlying) - Disposition from Tender
Common Stock
2008-08-05$4.15/sh−23,132$95,998→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2008-08-06−17,500→ 0 totalExercise: $3.35Exp: 2018-03-14→ Common Stock (17,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2008-08-06−1,500→ 0 totalExercise: $3.50Exp: 2014-01-19→ Common Stock (16,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2008-08-06−15,000→ 0 totalExercise: $3.50Exp: 2014-01-22→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Includes 21,766 shares of restricted stock which became fully vested pursuant to the terms of the Agreement and Plan of Merger dated June 23, 2008 between Barrier Therapeutics, Inc., Stiefel Laboratories, Inc. and Bengal Acquisition Inc. (the "Merger").
- [F2]This option was canceled in connection with the Merger in exchange for the right to receive the difference between the merger consideration of $4.15 per share and the option exercise price.